Mutational landscape, inhibitor development, and health‐care burden in non‐severe haemophilia A: A single‐centre Australian experience

Documenti analoghi

• Humanistic burden of haemophilia A without inhibitors: A cross‐sectional analysis of the HemoLIFE study
  di: María Teresa Álvarez‐Román, et al.
  Pubblicazione: (2024)
• Unearthing the genotype‐inhibitor phenotype association in severe haemophilia A: A north Indian cohort study
  di: Debadrita Ray, et al.
  Pubblicazione: (2024)
• The haemophilia joint health score for the assessment of joint health in patients with haemophilia
  di: Cihan Ay, et al.
  Pubblicazione: (2024)
• Genetic predictors for FVIII inhibitors formation in a Greek population of children with severe haemophilia A exclusively treated with recombinant concentrates
  di: Aikaterini Michalopoulou, et al.
  Pubblicazione: (2024)
• Prophylaxis with emicizumab in children under 12 years old with haemophilia A without inhibitors in Uruguay: National experience
  di: Felipe Lemos, et al.
  Pubblicazione: (2024)